From 2013 to 2023, South Africa's imports of pharmaceutical products have fluctuated, with a notable drop in 2016 followed by a recovery. In 2023, the value stood at $2.7078 billion. The 2022 year-on-year decline of 2.5% contrasts with a modest 2.27% increase in 2023. The compound annual growth rate (CAGR) over the past five years is 1.86%.
Looking forward, the forecasted imports show a steady increase with a 2028 projection of $2.9965 billion. The five-year CAGR is expected to be 1.53%, indicating a moderate growth rate. Key future trends include:
- Increased demand for pharmaceuticals due to demographic changes and a focus on healthcare improvements.
- Potential impacts of regulatory changes and market dynamics on import volumes.
- Rising influence of local pharmaceutical manufacturing affecting import dependency.
